Evaluation of decellularization protocols for production of tubular small intestine submucosa scaffolds for use in oesophageal tissue engineering  by Syed, Omaer et al.
Acta Biomaterialia 10 (2014) 5043–5054Contents lists available at ScienceDirect
Acta Biomaterialia
journal homepage: www.elsevier .com/locate /actabiomatEvaluation of decellularization protocols for production of tubular small
intestine submucosa scaffolds for use in oesophageal tissue engineeringhttp://dx.doi.org/10.1016/j.actbio.2014.08.024
1742-7061/ 2014 Acta Materialia Inc. Published by Elsevier Ltd.
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/3.0/).
⇑ Corresponding author at: Division of Biomaterials and Tissue Engineering, UCL
Eastman Dental Institute, 256 Grays Inn Road, London WC1X 8LD, UK.
E-mail address: j.knowles@ucl.ac.uk (J.C. Knowles).Omaer Syed a, Nick J. Walters a, Richard M. Day b, Hae-Won Kim c,d, Jonathan C. Knowles a,c,⇑
aDivision of Biomaterials and Tissue Engineering, UCL Eastman Dental Institute, 256 Grays Inn Road, London WC1X 8LD, UK
bApplied Biomedical Engineering Group, Division of Medicine, University College London, Gower St, London WC1E 6BT, UK
cDepartment of Nanobiomedical Science & BK21 Plus NBM Global Research Center for Regenerative Medicine, Dankook University, Cheonan 330-714, Republic of Korea
d Institute of Tissue Regeneration Engineering & College of Dentistry, Dankook University, Cheonan 330-714, Republic of Koreaa r t i c l e i n f o
Article history:
Received 28 January 2014
Received in revised form 24 July 2014
Accepted 22 August 2014
Available online 27 August 2014
Keywords:
SIS
Small intestine submucosa
Triton X-100
Tubular
SDSa b s t r a c t
Small intestine submucosa (SIS) has emerged as one of a number of naturally derived extracellular matrix
(ECM) biomaterials currently in clinical use. In addition to clinical applications, ECM materials form the
basis for a variety of approaches within tissue engineering research. In our preliminary work it was found
that SIS can be consistently and reliably made into tubular scaffolds which confer certain potential
advantages. Given that decellularization protocols for SIS are applied to sheet-form SIS, it was hypothe-
sized that a tubular-form SIS would behave differently to pre-existing protocols. In this work, tubular SIS
was produced and decellularized by the conventional peracetic acid–agitation method, peracetic acid
under perfusion along with two commonly used detergent–perfusion protocols. The aim of this was to
produce a tubular SIS that was both adequately decellularized and possessing the mechanical properties
which would make it a suitable scaffold for oesophageal tissue engineering, which was one of the goals of
this work. Analysis was carried out via mechanical tensile testing, DNA quantiﬁcation, scanning electron
and light microscopy, and a metabolic assay, which was used to give an indication of the biocompatibility
of each decellularization method. Both peracetic acid protocols were shown to be unsuitable methods
with the agitation-protocol-produced SIS, which was poorly decellularized, and the perfusion protocol
resulted in poor mechanical properties. Both detergent-based protocols produced well-decellularized
SIS, with no adverse mechanical effects; however, one protocol emerged, SDS/Triton X-100, which proved
superior in both respects. However, this SIS showed reduced metabolic activity, and this cytotoxic effect
was attributed to residual reagents. Consequently, the use of SIS produced using the detergent SD as the
decellularization agent was deemed to be the most suitable, although the elimination of the DNase
enzyme would give further improvement.
 2014 Acta Materialia Inc. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/3.0/).1. Introduction
The oesophagus as an organ can be affected by a number of
medical conditions which may necessitate the need for extensive
treatment to correct. These conditions can be congenital, such as
oesophageal atresia, which is a paediatric condition where the
oesophagus forms incorrectly, or alternatively they can be acquired
conditions, such as oesophageal cancer [1–3]. Treatment for these
conditions can include complicated surgical procedures, such as
gastric transposition or intestinal interposition [4]. These tech-
niques are unfortunately associated with a number of post-opera-
tive complications, including stricture formation, anastomoticleakages, dysphagia, dysmotility and gastro-oesophageal reﬂux,
which can itself can lead to abnormal cell growth, potentially lead-
ing to neoplasia [5,6]. One approach which may provide an alterna-
tive is the use of tissue engineering to creative a viable
biomaterial-based replacement for oesophageal tissue.
Clinically successful extracellular matrix (ECM) materials pre-
dominantly consist of allogeneic and xenogeneic decellularized tis-
sues. Those tissues commonly in use are urinary bladder matrix,
skin, pericardium and small intestine submucosa (SIS), which have
all been used for a variety of clinical applications and are derived
from human, bovine and porcine sources [7]. The beneﬁts of ECM
materials, such as SIS, are related to their effects post-implantation,
including the release of growth factors and biologically active cryp-
tic peptides upon degradation, which then inﬂuence the important
processes of angiogenesis, mononuclear inﬁltration, cell prolifera-
tion, cell migration and cellular differentiation [8,9]. The materials
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cit a limited immune response restricted to Th2 lymphocytes, in
line with graft acceptance, and which differs from the Th1 lympho-
cyte-mediated response commonly associated with xenogeneic
graft rejection [10,11]. There is also an increased presence of alter-
natively activated M2 macrophages and associated low levels of
pro-inﬂammatory cytokines [12,13]. In summary, the advantages
of SIS include relatively rapid degradation by non-immunogenic
means and a restricted immune response, in conjunction with
the release of growth factors which can contribute towards con-
structive tissue remodelling and new tissue formation [14].
SIS has successfully been used as an oesophageal patch within
in vivo models for the repair of the oesophagus [15,16]. However,
SIS sutured into a tubular form and used for segmental oesopha-
geal replacement in a canine model did not function well, with ste-
nosis and detachment being the major causes of failure [17]. The
mechanical properties, including the stress to failure of the mate-
rial, were given as one of the principle causes for this failure and
it was proposed that, had a biodegradable stent been present dur-
ing the initial 3 month period, when the majority of failures
occurred, it may have been possible to prevent some of the
observed failures. This is in accordance with the consensus view
that one of the major limitations of ECM materials such as SIS is
that they do not possess the mechanical properties for relatively
large tissue reconstruction roles or for resisting the stresses pres-
ent in applications like rotator-cuff injury repair, where clinical tri-
als have been unsuccessful [18,19].
In this work, it was investigated whether SIS could function bet-
ter for oesophageal tissue engineering if it was produced in an
intact tubular form, as opposed to the regular sheet form. It was
hypothesized that the lack of a seam would be an advantage not
only for the potential for improved performance, but also with a
view to allowing further modiﬁcation of the SIS. The ﬁrst stage of
this was to investigate the creation of a tubular SIS. Peracetic acid
under agitation has been the standard decellularization protocol
for production of SIS sheets for a number of years [20,21]. How-
ever, with the SIS in tubular form, an alternative decellularization
protocol was considered necessary to allow for the tissue to be
adequately decellularized. Perfusion decellularization protocols
have been successfully applied to a variety of tissues, and a large
number of protocols and agents exist [22,23]. In this study, the
two protocols selected have been used to decellularize a variety
of tissues, and these two were compared to peracetic acid under
agitation, along with an undecellularized control, to obtain an opti-
mal decellularization protocol for tubular SIS. In addition to this, to
draw a fair comparison between the effectiveness of the reagents
in the different protocols, peracetic acid was also tested using
the perfusion arrangement.
The ﬁrst method was a perfusion method applied by Ott et al.
[24] to decellularize intact rat hearts. This method involved the
use of two detergents: sodium dodecyl sulfate (SDS), an anionic
detergent, and Triton X-100 (t-octylphenoxypolyethoxyethanol),
a non-ionic detergent considered to be non-denaturing [22]. Both
detergents are commonly used for cell lysis applications. SDS has
been used for a number of years and on a variety of tissue types,
including less commonly decellularized tissues, such as the kidney
and temporomandibular joint [23]. The use of Triton X-100 has
also been quite prominent in the ﬁeld of tissue engineering and
was used for decellularization by Cortijo et al. as early as 1987
[25], when it was applied to a number of different tissues, includ-
ing the ileum, arteries and muscle tissue. The method used by Ott
et al. [26] was replicated by Akhyari et al. and was shown to be one
of two better performing methods for whole heart decellulariza-
tion in a comparison of four different protocols.
The second protocol involved a combination of sodium deoxy-
cholate (SD) and deoxyribonuclease I (DNase). Early work doneby Meezan et al. [27] isolated basement membranes from a variety
of tissues, including bovine retinal and brain blood vessels, rabbit
renal tubules and rat renal glomeruli, all using 4% SD and DNase.
A modiﬁed version of this method was used in the decellulariza-
tion of the trachea by Conconi et al. [28]. The method was used
in the form of repeated cycles, which had the effect of producing
a decellularized donor trachea, which was subsequently implanted
into a patient [29]. This method was also then used by Totonelli
et al. [30], who applied it to the decellularization of the rat small
intestine using a perfusion-based method. In summary, the
method described has shown a degree of effectiveness on a num-
ber of tissues when used in a perfusion-based protocol. It has been
applied to scaffolds which have then gone on to be successfully
implanted into a patient, and is therefore highlighted as an effec-
tive method for perfusion decellularization.
For any ECM to function in vivo it must be adequately decellu-
larized, as the presence of cell membrane epitopes and xenogeneic
or allogeneic DNA could result in an adverse immune response
upon implantation [31]. In reviewing decellularization, Crapo and
Gilbert [23] proposed three criteria for satisfactory decellulariza-
tion, two of which are suitable for this work, namely: <50 ng of
double stranded DNA (dsDNA) per mg of ECM (dry weight) and a
lack of visible nuclear material in tissue sections stained with
40,6-diamidino-2-phenylindole or haematoxylin and eosin (H&E).
The third criterion suggested was a < 200 bp DNA fragment length,
but this is beyond the scope of this work. It should be stated that
these criteria are being used herein as no substantial work has
been carried out which establishes the threshold level of cellular
remnants in ECM materials that elicits a negative remodelling
response. Additionally, should any of the protocols produce a SIS
which is mechanically unsound, it would not be considered a suit-
able protocol.2. Materials and methods
Frozen samples of porcine small intestine were obtained at a
local abattoir from animals that were 6 months in age. The jeju-
num/ileum samples were cut into lengths of 20 cm and the excess
mesentery tissue removed (Fig. 1a). The samples were rinsed thor-
oughly with deionized water to remove debris.
The SIS was isolated using slight modiﬁcations to the well-
established method [32,33]. The sections of small intestine were
inverted and then gently abraded using moist surgical gauze to
remove the inner mucosal layer. The tissue was thoroughly washed
with deionized water and then re-inverted, and the serosal layer
was then taken off by ﬁrst creating an incision with a scalpel, then
manually removing the layer. Finally, the outer surface was care-
fully abraded using damp gauze to remove any remnants of the
smooth muscle layers. The SIS was then carefully washed twice
in deionized water for 5 min, before being stored in phosphate-
buffered saline (PBS: 0.01 M phosphate buffer, 0.0027 M potassium
chloride and 0.137 M sodium chloride, pH 7.4, at 25 C). Represen-
tative tissue samples were collected throughout the process and
used as control samples.2.1. Decellularization
2.1.1. Method 1 (perfusion/immersion)
Prepared SIS samples were placed in individual glass containers,
secured to adaptors and connected to a multi-channelled peristal-
tic pump (Watson-Marlow, Cornwall, UK). The complete arrange-
ment is illustrated in Fig. 2. The input channels were also
secured in the same containers. The solutions described below
were then placed in the containers to create an isolated chamber
and the pump was run to begin perfusion.
(a)                      (b)                      (c)                (d) 
Fig. 1. (a) Porcine small intestine section prior to debridement. (b) SIS following decellularization. (c, d) Final processed form of SIS.
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sue and collect in the vessel, where it further immersed the sam-
ples while also recycling back to the pump. The beneﬁt of this
arrangement is that there is also an element of immersion decell-
ularization which occurs on the outer surface of the SIS samples.
Twelve samples were produced simultaneously using this
arrangement.
2.1.1.1. Sodium dodecyl sulfate & Triton X-100 (SDS/TX). The previ-
ously described protocol was altered for this particular application
in terms of reducing the number the cycles to a single cycle. Each
container was ﬁlled with 350 ml of 1% solution of SDS (Sigma–
Aldrich Company Ltd., Dorset, UK), then the pump was run at
500 ml h1 for 12 h at room temperature (RT). The SIS was
removed and thoroughly rinsed with deionized water, followed
by a perfusion wash for 15 min with deionized water. The samples
were then perfused with 350 ml of 1 vol.% of Triton X-100 for
30 min, rinsed and then perfused with deionized water for
15 min. The decellularized SIS was then rinsed with deionized
water and soaked for 30 min in deionized water prior to being
given a ﬁnal rinse. All decellularized SIS was stored at 4 C in
PBS. Changes from the protocol as outlined by Akhari et al. [26]
include removing steps which were suited to heart decellulariza-
tion, including the use of a ﬁnal stage where the perfusion is
allowed to carry on for an additional 124 h in PBS containing
penicillin-G, streptomycin and amphotericin B.
2.1.1.2. Sodium deoxycholate & DNase (SD/DN). The procedure here
was carried out as described above. Each container was ﬁlled with
350 ml of 4% SD (Sigma–Aldrich), then the pump was run atFig. 2. Decellularization container arrangement. (a) Output from the peristaltic
pump, which is connected to the SIS. (b) Return to the peristaltic pump, which is not
connected to the SIS and draws the medium from the container. (c) The SIS to be
decellularized. (d) Container into which the decellularization medium will collect
and immerse the external surface of the SIS. The red arrow indicates the direction of
ﬂow of the perfusion decellularization medium.500 ml h1 for 12 h at RT. The samples were removed and thor-
oughly rinsed with deionized water followed by a perfusion wash
for 15 min, also with deionized water.
The SIS was then perfused with DNase I (Sigma–Aldrich) at a
quantity of 2000 kU in 300 ml of 1 M NaCl solution at RT for 3 h.
At the 3 h mark an additional 1000 kU in 50 ml of 1 M NaCl was
added and run for a further 1 h. This was followed by rinsing, a
ﬁnal perfusion and soaking in deionized water, as described previ-
ously. The samples were stored at 4 C in PBS. The original protocol
was run in a number of ‘‘cycles’’, and as a result the time was
extended from 4–6 h to 12 h to simulate approximately two cycles.
The DNase I amount was increased to 3000 kU (from 2000 kU in
the original protocol), and the time was extended to 4 h (from
3 h) [34]. The additional quantity of enzyme (1000 kU) was only
added in the ﬁnal hour.2.1.1.3. Peracetic acid (PAA-12h). Peracetic acid was used for the
ﬁnal perfusion protocol. This was run as described above but using
350 ml of a 0.1 vol.% solution of peracetic acid per length of SIS for
12 h at RT.2.1.2. Method 2 (immersion/agitation)
2.1.2.1. Peracetic acid (PAA-2hA). SIS samples used were placed in
screw-top specimen containers (150 ml capacity) and were placed
on an orbital shaker (Stuart Model SSM1, Keison Products, Chelms-
ford, UK) to provide mechanical agitation. The containers were
ﬁlled to capacity with a 0.1 vol.% solution of peracetic acid
(Sigma–Aldrich), with care taken to immerse the samples com-
pletely and remove any trapped air bubbles. Decellularization in
peracetic acid was carried out for 2 h under mechanical agitation
at 100 rpm. The SIS samples were removed and thoroughly washed
in deionized water as described previously, and stored at 4 C in
PBS. A summary of these methods are shown in Table 1.2.2. Post-decellularization processing
The SIS sections were stretched over 1.9 cm diameter (3/4 inch)
porous polyethylene tubing (60 micron pores) (Porex Corporation,
Fairburn, United States). These samples were vacuum-dried in
sealed sterile specimen bags and placed under low vacuum condi-
tions (approximately 10 mbar) for 12 h to compress and dry the
samples. The dried SIS samples were subsequently lyophilized by
immersing in liquid nitrogen for 1 min and then placed into a vac-
uum freeze-drier (Heto Drywinner, Birkerod, Denmark) for 12 h.
The ﬁnal appearance of the processed SIS is shown in Fig. 2(c)
and (d). The further processing allowed creation of SIS with a
smooth and regular surface. The lyophilization also aided in
extending the storage capacity of the SIS.
Table 1
Experimental conditions for SIS production.
Decellularization method Reagents Method Samples tested Processed
and tested
Total number
of sample sets
uSIS Untreated – Untreated Yes 2
PAA-2hA Peracetic acid Immersion/Agitation 2 h Yes 2
PAA-12h Peracetic acid Perfusion 12 h Yes 2
SD/DN Sodium deoxycholate & DNase Perfusion 4 h, 8 h, 12 h and ﬁnal stage (16 h) Yes 5
SDS/TX Sodium dodecyl sulfate & Triton X-100 Perfusion 4 h, 8 h, 12 h and ﬁnal stage (12.5 h) Yes 5
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For the two detergent-based protocols (SDS/TX and SD/DN),
sections were taken from the SIS at time points of 4, 8 and 12 h,
and upon completion of the protocol, by cutting 2.5 cm segments
during decellularization. Due to the presence of two stages in these
protocols, i.e. a 12 h stage followed by a shorter stage, the decision
was taken to test the tissue at regular intervals to assess the impact
of time and the ﬁnal stages.
Sections were also taken from SIS produced from the PAA-12h
and PAA-2hA groups, and the untreated control SIS (uSIS). Test sec-
tions were also taken from all SIS samples following processing.
The sample segments were then sectioned further and stored
according to the method of analysis.
2.3.1. Histology
SIS samples to be processed for histology were ﬁxed in 10% for-
malin. The samples were embedded in parafﬁn wax, sectioned to
3 lm thickness and stained by H&E and elastic-Van Gieson stain
(EVG). Images of the sections were acquired using a light micro-
scope (Olympus BX50, Olympus Optical Co (UK) LTD, London,
UK) and analysed using Image-Pro Plus (Media Cybernetics, Rock-
ville, USA) and Image J.
2.3.2. Scanning electron microscopy (SEM)
Non-lyophilized samples were ﬁxed in 3% (w/v) glutaraldehyde/
0.1 M CAB (sodium cacodylate) buffer for 3 h. After rinsing with
PBS, the samples were dehydrated by separate 15 min immersions
in graded ethyl alcohol concentrations (50, 70, 90 then 100 vol.% in
deionized water), then brieﬂy immersed in hexamethyldisilazane
for critical point drying. Sections of dehydrated SIS were cut
(1 mm thickness) and mounted on aluminium stubs. Lyophilized
samples were cut into 0.5 mm-sided squares and directly mounted
on aluminium stubs using adhesive tabs. The stubs were then
placed in a desiccator cabinet for at least 12 h to ensure any
acquired moisture was sufﬁciently removed. All sections were then
sputter coated with gold/palladium (Polaron E5000, Quorum
Technology, UK). The samples were then analysed using a scanning
electron microscope (JEOL 5410LV SEM, JEOL UK, Herts, UK).
2.3.3. DNA quantiﬁcation
To dry the non-lyophilized samples, these were ﬁrst frozen and
stored at 20 C and then placed in a freeze dryer for 6 h. DNA
extraction was carried out using a DNeasy Blood & Tissue Kit 50
(Qiagen, Hilden, Germany). The DNA was quantiﬁed using a
Quant-iT™ DNA Assay Kit or Qubit dsDNA HS Assay Kit (Invitro-
gen, Carlsbad, USA), a ﬂuorescence plate reader (Fluoroskan Ascent,
Thermo Scientiﬁc, USA) or a Qubit Fluorometer (Invitrogen, USA).
2.3.4. Mechanical testing
Uniaxial tensile testing was carried out using a dynamic
mechanical analyser (DMA 7e, Perkin-Elmer Instruments, USA).
Test sections were cut into rectangular shapes of dimensions
8–14 mm in length and 5–8 mm in width, and in both the longitu-
dinal and circumferential directions (relative to the axis of thesmall intestine). The ends of the samples were enclosed in wire
gauze to provide grip and stability, and the samples were then
clamped into the machine. The dimensions of the samples were
entered into the software (Pyris, Perkin-Elmer Instruments, Akron,
USA) and the distance between the two clamps was taken as the
length. The tensile test was run with an increasing force value of
500 mNmin1. From the stress–strain graph produced, the elastic
modulus was calculated as the gradient of the elastic region of
the curve (k = stress/strain). Processed SIS was rehydrated with
deionized water for 30 min, prior to testing. Samples which slipped
or failed near to the clamps were ignored.
2.3.5. Statistical analysis
Basic statistical assessment of the data showed that it did not ﬁt
standard normal distribution models and therefore non-paramet-
ric statistical analysis methods were chosen. The median was
deemed to be a better measure of the central tendency than the
mean for this particular data, so is used in all the analyses. The
group sample data was compared for signiﬁcant differences using
Kruskal–Wallis non-parametric analysis, which indicates the pres-
ence of signiﬁcant statistical differences between individual
groups. Further analysis was also carried out by post-hoc pairwise
analysis (Dunnett’s test). All statistical signiﬁcance tests were per-
formed using SPSS version 21 (IBM Corporation, Armonk, NY, USA).
2.3.6. Cell culture
Primary human esophageal smooth muscle cells (HESMC; Sci-
enCell Research Laboratories, Carlsbad, CA, USA) were cultured in
Dulbecco’s modiﬁed Eagle’s medium (Gibco, Life Technologies,
Paisley, UK) supplemented with 10% foetal bovine serum (Gibco)
and 1% penicillin–streptomycin (Gibco) at 37 C in air, with 5%
CO2 and 95% relative humidity. Cells from passages 3–6 were used
for experiments.
2.3.7. Biocompatibility assay
A CellTiter 96 AQueous Non-Radioactive Cell Proliferation Assay
(Promega, Southampton, UK) was used to assess the enzymatic
activity of HESMC as an indication of biocompatibility, in accor-
dance with ISO 10993 parts 5 [35] and 12 [36] and the manufac-
turer’s protocol. Brieﬂy, HEMSC were seeded at a density of
100,000 cells cm2 on PAA-12h, PAA-2hA, SDS/TX, SD/DNA, uSIS
and a commercial scaffold, with tissue culture plastic (TCP) as a
control. The commercial scaffold was Biodesign (Cook Medical,
Bloomington, USA) and was used in this instance only to provide
a potential alternative to TCP as a control. Cell culture inserts (Cell-
Crown, Scaffdex Ltd., Tampere, Finland) were used to pull the sam-
ples taut and suspend them within the 24-well plates with the
cells seeded on the abluminal surface, with the exception of the
commercial scaffold, which did not have a speciﬁed orientation.
The scaffolds were all hydrated with 200 ll of medium approxi-
mately 30 min prior to seeding cell. After incubation for 24 or
96 h, medium was aspirated from the cells and replaced with one
part of MTS solution in six parts of medium, which consists of
(3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-
(4-sulfophenyl)-2H-tetrazolium) (MTS dye) and the electron
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form formazan in the mitochondria of living cells, resulting in a
colour change from yellow to brown that is indicative of cell num-
ber. After sufﬁcient colour change was observed (after incubation
for 1–1.5 h), absorbance was measured at 490 nm, with a reference
wavelength of 630 nm. The metabolic activity of cells residing on
each scaffold was normalized to the TCP control, speciﬁc to each
time point. Between time points, the MTS-containing medium
was aspirated, the cells were rinsed with PBS, and the medium
was replaced with fresh cell culture medium.
3. Results
3.1. Histology
Staining with H&E revealed the presence of visible and distinct
nuclei in all samples (Fig. 3), with the number of nuclei in the ﬁnal
samples being SDS/TX < PAA-12h < SD/DN < PAA-2hA < uSIS
(Fig. 6a). The numbers of visible nuclei per square micrometre
were found to be far higher in the uSIS control and PAA-2hA groups
than in the ﬁnal stages of SDS/TX, SD/DN and PAA-12h. The SDS/TX
group was observed to have the lowest number of histologically
visible nuclei per square micrometre of visible tissue by a substan-
tial margin. Staining with EVG showed a quite even dispersal of
black-stained elastin ﬁbres throughout the intestinal tissue. The
decellularization process did not appear to result in any visible loss
of elastin ﬁbres by any of the protocols (Fig. 4).
3.2. SEM
The use of SEM imaging did not reveal any visible differences
between samples of the ﬁve groups (Fig. 5). There were also no vis-
ible differences between samples taken from different time points
during the longer multi-stage protocols (SDS/TX and SD/DN). The
ﬁbrous structure of the pre-processed SIS samples was clearly visi-
ble on some images (Fig. 5d). The processed form of the SIS pro-
duced a characteristic sheet-like regular appearance (Fig. 5h) in
most samples, with the exception of the processed PAA-12h, which
had a characteristic appearance of a more cracked surface with
defects (Fig. 5f and g).
3.3. DNA quantiﬁcation
DNA quantiﬁcation revealed that the SDS/TX group
produced samples with the lowest levels of DNA following the(a)             (b)
          (e) 
Fig. 3. Histological images (stained with H&E): (a) uSIS, (decellularization process (Fig. 6b). SD/DN also proved to be effec-
tive at decellularization producing DNA levels well below the uSIS
control. The level of DNA present in the PAA-2hA group was not
signiﬁcantly different to that of the control. The level of DNA pres-
ent in the PAA-12h group was not signiﬁcantly different from the
control but was signiﬁcantly lower that the PAA-2hA group.
It was also observed that SD/DN produced no appreciable differ-
ence in the DNA quantity detected between the 12 h time point
and the ﬁnal stage (16 h), indicating that the introduction of the
enzyme DNase did not affect the quantity of the DNA remaining
in the SIS.3.4. Mechanical analysis
In longitudinal testing, the elastic modulus values did not vary
signiﬁcantly between the specimens with the exception of the
PAA-12h, which had increased values in both directions, with the
longitudinal value being exceptionally high when compared to
the other groups (Fig. 7a). It was observed that, following decellu-
larization, the SIS produced from the PAA-12h protocol was phys-
ically different to all other SIS samples when handled. The SIS in
this group took on a more ridged and less pliable texture not
observed in any of the other groups. Lyophilization of the samples
did not affect the elastic modulus values, with the exception of the
PAA-12h group, which fell dramatically, and the SDS/TX group,
which, when compared longitudinally with the pre-lyophilized
form, showed a signiﬁcant increase.
The yield stress was considered a useful parameter as the data
mirrored that of the failure and indicates the stress at which the
tissue undergoes mechanical compromise. The calculated yield
stress values showed no signiﬁcant change between the specimens
with the exception of the PAA-12h sample, which again was found
to be signiﬁcantly larger, particularly in the longitudinal direction
but also circumferentially, when compared to the other pre-lyoph-
ilized SIS (Fig. 7b). The lyophilization here was found to cause
slight increases in all samples, with the increase in SDS/TX being
quite substantial, though with the exception of the PAA-12h group,
which fell in longitudinal testing. The only signiﬁcant circumferen-
tial increase was found in the PAA-12h specimens, which showed a
substantial increase in the yield strain value. Again, it should be
noted here that the PAA-12h SIS produced greatly different behav-
iour when compared to the other samples.
The failure strain was calculated as the actual point of failure of
the testing sample during the tensile test. In the longitudinal testing,(c)             (d)  
b) PAA-2hA, (c) PAA-12h, (d) SD/DN and (e) SDS/TX.
(d) 
   (a)    (b)  
(e)
(c) 
Fig. 4. Histological images of decellularizing SIS and the controls (stained with EVG): (a) uSIS, (b) PAA-2hA, (c) PAA-12h, (d) SD/DN and (e) SDS/TX.
(a)                        (b)   (c)                        (d) 
(e)                        (f)                            (g)                        (h) 
Fig. 5. SEM images of SIS from the protocol groups. All are taken from a cross-sectional view unless speciﬁed: (a) uSIS, (b) PAA-2hA, (c) PAA-12h, (d) SD/DNase, (e) SDS/TX, (f)
luminal view of processed PAA-12h, (g) processed PAA-12h and (h) processed SD/DNase.
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groups were all found to be similar to the control uSIS or the PAA-
2hA group (Fig. 7c). It was also noted that the value for PAA-12h
was found to be very low (39.29%), with a very low error, indicating
that, while the PAA-12h was very stiff and gave high yield strength
values, thematerial had a greatly reduced elasticitywhen compared
to the control uSIS or the other samples. In circumferential testing,
only the PAA-12h failure strain value was found to be signiﬁcantly
lower than that of the control uSIS. Following lyophilization, the
PAA-12h SIS was observed to change in failure strain behaviour,
with the value increasing following the processing.
The results from the 12 h detergent decellularization stages (at
time points of 4, 8 and 12 h) in both the SD/TX and SD/DN groups
(Fig. 8) do not appear to indicate any quantiﬁable time-dependant
changes in the mechanical properties of the SIS by the criteria
which were investigated.3.5. Biocompatibility
The results of the biocompatibility assay were expressed in
terms of metabolic activity and are represented as a percentage
in relation to the TCP control for that time point (Fig. 9). At day 1
(24 h), the SIS specimens from the PAA-2hA and PAA-12h groups
were found to have metabolic activity levels which were similar
to the TCP control, while the SD/DN and the commercial SIS groups
were found to be elevated at to levels 1.5 and 2 times greater,
respectively. The uSIS group was found to have highly elevated
metabolic activity, with the average value being approximately 4
times that of the control group TCP group, indicating a very rapid
increase in the metabolic activity of the cells. Conversely, the
SDS/TX group was found to have signiﬁcantly lower values
than the control TCP and all other samples, indicating lower
biocompatibility.
(a) 
(b)
Fig. 6. (a) The average number of distinct nuclei counted per square micrometre of SIS for all SIS groups. Analysis was carried out on images taken of H&E-stained histological
sections, with random sites chosen and the nuclei counted using software (Image J) (n = 10–20). All counts were then averaged together for each stage. Error bars show the
standard error. (b) DNA quantiﬁcation values (ng per mg dry weight) for the three protocols and the control, with each column representing the concentration of DNA at
various time points in the decellularizing protocols, including the processed SIS (n = 4). Error bars show the standard error.
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activity from the levels at day 1, including the TCP group. The
SDS/TX specimens still induced very low activity levels, which at
day 4 remained lower than all other groups at day 1, indicating
ongoing cytotoxicity. Both PAA groups performed similarly to the
TCP control group, indicating a reasonable degree of biocompatibil-
ity. At day 4, the SD/DN, commercial SIS and uSIS groups all
showed numbers at least twice that of the relative TCP value.
While the uSIS group ﬁnished with the highest activity level, there
was also a decrease relative to the control, indicating a levelling off
of the sudden increase in the ﬁrst 24 h.
4. Discussion
The aim of this study was to evaluate commonly used decellu-
larization protocols to create tubular SIS which has a sufﬁcient
level of decellularization to function as a tissue engineering scaf-
fold, yet possesses mechanical properties that are either minimally
affected or, ideally, unaffected by the decellularization process. The
perfusion method has not been applied to SIS previously, but washypothesized to be suitable on account of the shape of the tubular
SIS.
The data from histological evaluation and quantitative DNA
analysis show that the most effective protocol was the SDS/TX.
The SIS produced by this method largely achieved both the criteria
highlight by Crapo and Gilbert [23]: being below the 50 ng of
dsDNA per mg of ECM (dry weight) and having no histologically
visible nuclei. While it is understood that no work has been carried
out that evaluates these criteria as indicators of sufﬁcient decellu-
larization, it is logical that minimizing the amount of foreign DNA
present in any type of graft tissue would likely increase the chance
of successful implantation due to a reduced immune response. It
was also found that both detergent-based perfusion methods pro-
duced SIS with DNA below the 50 ng of dsDNA per mg of ECM (dry
weight) threshold, and that both methods using peracetic acid did
not adequately decellularize SIS, though there was a signiﬁcant dif-
ference between the two. The question arises as to whether this is
due to the effectiveness of the reagents or the time duration of the
protocols, or is a result of the physical process of the protocols
themselves.
(a)
(b)
(c)
Fig. 7. Mechanical tensile testing data from all ﬁnal stage SIS groups, along with the lyophilized forms (n = 12). (a) Elastic modulus values (MPa). (b) Yield stress values (MPa).
(c) Failure strain (%). Error bars show the standard error.
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evidence to suggest that, using a number of different criteria, they
can all be considered highly effective at decellularization. When
applied to sheet SIS, peracetic acid is known to be an effective
reagent for decellularization. SDS and Triton X-100 have also been
shown, by Oliveira et al. [37], to have the capacity to decellularize
SIS individually to levels below 50 ng of dsDNA per mg using con-
centrations as low as 0.1% over a 24 h period under agitation. SD,
while not having been used on SIS, has been shown to decellularize
the small intestine in a rat model [30]. Consequently, all three
agents are likely to be effective at decellularizing SIS. Therefore,
the failure of the SIS to decellularize in this study particularly usingPAA is likely not to be due entirely to the effectiveness of the
reagent but is more likely to be due to the decellularization meth-
ods or the shape and structure of the tissue.
The length of time the protocols are run is another important
factor. The level of DNA present in the detergent-based protocols
(Fig. 6b) can be seen to steadily decrease over time, which
undoubtedly shows that time is a vital component of the decellu-
larization process. Time has also been shown to effect peracetic
acid decellularization, and halving the decellularization time to
1 h results in elevated levels of DNA when compared samples
run for 2 h [12]. In addition to this, the increased effectiveness of
the PAA-12h perfusion protocol (in comparison to the PAA-2hA
 (a)
(b)
(c)
Fig. 8. Mechanical data from tensile testing SIS from the two detergent-based protocols (SDS/TX and SD/DN) taken from different time points during the decellularization
process. The three criteria used in the analysis are: (a) elastic modulus (MPa), (b) yield stress (MPa) and (c) failure strain (%). Error bars show the standard error.
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acetic acid decellularization; however, while the amount of DNA
was reduced slightly, the number of nuclei visible suggests a less
than optimum level of decellularization (Fig. 3c).
The ﬁnal difference between the protocols was the decellular-
ization arrangements themselves. As mentioned above, there are
no examples of SIS being decellularized using a perfusion arrange-
ment and no work where the intact tubular size was consistently
studied. Perfusion decellularization has been used on rat small
intestine using 4% SD/DNase, and this was found to be an effective
means of decellularization; however, the analysis was limited to
the histological means [38]. Multi-organ decellularization of rat
tissues using SDS perfusion has also been shown to be effectiveat decellularization [39]. In the case of this work, however, it is
unclear whether the SIS was actually undergoing true perfusion
through the SIS itself. SIS is a largely impermeable tissue and, given
the low ﬂow rates used, it is highly unlikely that the decellulariza-
tion agents perfused through the thickness of the tissue. The com-
bination of a constant ﬂow of decellularizing agents over the
luminal surface of the SIS in addition to the circulating agents on
the outer surface, however, has likely produced an environment
where suitable decellularization can occur simultaneously on both
surfaces and consequently provides a working method for decellu-
larizing tubular SIS.
One of the major observations in the mechanical testing was
the extreme variations in the data produced by the PAA-12h
Fig. 9. Metabolic activity of the cells (HESMC) cultured on the scaffold groups. The metabolic activity was normalized in relation to the control (TCP with the same surface
area), and is expressed here as a percentage of the control, speciﬁc to each time point. The dashed line indicates the metabolic activity of the TCP control at each time point.
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stress values were also accompanied by a drastic drop in the fail-
ure strain to the lowest of all the SIS samples, at just below 40%.
This is indicative of SIS tissue which has lost a high degree of elas-
ticity when compared to the control; as a result, this SIS can be
reasonably excluded from consideration. Furthermore, the human
oesophagus also extended by up to 50% under normal conditions,
and any material which has a failure strain below this level risks
failing and compromising the integrity of the construct [40,41].
The SIS produced by peracetic acid under agitation (PAA-2hA)
appeared to match the control and the SIS from the detergent-
based protocols in its mechanical behaviour; however, as already
described, it was poorly decellularized and is therefore not suit-
able as a scaffold. The short exposure of the SIS to the peracetic
acid is the likely cause of the difference between the two proto-
cols. Currently there does not appear to be any deﬁnitive consen-
sus on the effects of individual decellularization agents on the
mechanical properties of many of the commonly used decellular-
ized tissues [23]. It has been shown that some acids, when used
on ECM, can alter its mechanical properties. An example of this
is acetic acid, which has been shown to alter the stress–strain
behaviour of bovine pericardium [38]. Peracetic acid has not been
reported to alter the mechanical properties of SIS, though, as in
the case here, the time of exposure was commonly limited to
2 h [22,39].
The two detergent-based protocols also produced decellular-
ized SIS, which was not adversely affected by the decellularization
process according to the three criteria which were used for evalu-
ation. Of the two protocols, only SDS/TX produced SIS with high
values for all three criteria, particularly in terms of the lyophilized
form. It should be mentioned that detergents have also been
known to disrupt the ECM matrix; however, this was not observed
in this study [23]. A possible reason for this is that both of these
protocols were adapted in this study to reﬂect the nature of the
SIS, which only consists of a thin layer of predominantly ECM,
and were therefore run for a shorter time. In the case of other tis-
sues, these profusion protocols are run for a large number of
repeated cycles. A variation of the SD/DNase protocol has been
used to decellularize a human donor trachea, a process that takes
multiple cycles, though it was found that, between cycles 18 and
22, the mechanical properties were so negatively impacted as to
render the trachea ineffective [34]. Consequently, the limitedexposure of the detergents to the tissue in this work could be the
reason for the preservation of the mechanical properties.
A number of inconsistencies were observed in the mechanical
testing between the longitudinal and circumferential tensile data.
This was attributed to the native anisotropy found to be present
in SIS having a high degree of complexity [42]. If both axes are
secured simultaneously and a force is applied along one axis, this
would directly result in changes in the stress–strain behaviour
along the other axis. This behaviour was also found to be asymmet-
ric with the application of a set force along the longitudinal axis,
resulting in changes to the circumferential stress–strain behaviour
which were more pronounced than if the axes were reversed [43].
This anisotropy has been explained by the angular distribution of
the ﬁbres within the ECM of the submucosal layer [44]. These
ﬁbres have been described as two distinct populations of ﬁbres ori-
entated at approximately ±30 [42,43]. Sacks and Gloeckner [43]
found the ±30 orientated layers to be part of local subdivisions
within the tissue, which can vary along its length. This is also rein-
forced by the description of the ﬁbres being aligned in a spiral,
which can be considered conducive to peristalsis [45].
The vacuum-compression and lyophilization of the SIS was
found to alter its mechanical properties. The exact mechanism
for these changes is not entirely clear, though the differences
between the longitudinal and circumferential directions can be
partially explained in terms of the native anisotropy of the tissue,
as mentioned above. What can be observed from the data in
Fig. 7 is that there were changes, at least along the longitudinal
direction, particularly in terms of the failure strain for all samples.
A possible mechanism for this is that the vacuum compression of
the SIS results in an increased level of interaction between the
ECM components – particularly the collagen ﬁbres – present,
thereby altering the mechanical properties. It should be noted that,
following rehydration, the processed samples did not expand to
the same thickness as the pre-processed SIS samples. In addition
to changes in the mechanical properties, it has been shown that
processing decellularized SIS can cause a change to the in vivo
properties. When vacuum-pressed SIS was compared to lyophi-
lized SIS, the vacuum-pressed SIS was found to be more resistant
to enzymatic degradation, and angiogenesis was also observed to
occur at a slower rate due to slower rates of cell inﬁltration. The
compressed SIS test was found to have a far lower degree of poros-
ity and retained a compressed appearance after rehydration [46].
Fig. 10. Metabolic activity of the cells (HESMC) cultured on the SDS/TX scaffolds, showing the difference between the SDS/TX original protocol and an adapted protocol with
an extended washing regime (increased to 6 h, with a continuous ﬂow of fresh deionized water). The metabolic activity was normalized in relation to the control (TCP with
the same surface area), and is expressed here as a percentage of the control, speciﬁc to each time point. The commercial scaffold was added as a reference point for
biocompatibility. The dashed line indicates the metabolic activity of the TCP control at each time point.
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ation for their potential future use. The data here showed clear dif-
ferences between decellularization protocols. While both peracetic
acid protocols showed a good degree of biocompatibility, cells cul-
tured on the SDS/TX had lower levels of metabolic activity than all
the other samples, including the control. While the SIS produced
from this method was found to be most ideal both mechanically
and in terms of the decellularization, this level of biocompatibility
makes it highly unsuitable. Furthermore, follow-up work (Fig. 10),
where SDS/TX was created and then washed for 6 h using an
improved washing method, failed to signiﬁcantly improve the bio-
compatibility. This protocol involves the use of two separate deter-
gents which have each been shown to be cytotoxic, i.e. SDS and
Triton X-100, and with this increased exposure there is also an
increased likelihood of some detergent being retained within the
SIS itself.
SD is also a cytotoxic detergent and it should be noted that, in the
SD/DN protocol, which had the best biocompatibility of all the
decellularized SIS produced, the SIS was exposed to a 4 h rinse with
a salt solution (containing theDNase) following detergent exposure.
This could potentially have aided in removing the detergent sufﬁ-
ciently from the SIS to produce the observed results. It should be
noted that, while SIS produced with the SD/DN protocol had a very
high biocompatibility (higher than the commercial SIS), the pres-
ence of the DNase enzyme, though likely to have a minimal effect
on cell growth in vitro, may have a more negative effect if applied
in vivo.
The uSIS demonstrated a high degree of biocompatibility, which
could be explained if the internal structure was preserved and the
tissue components retained. An intact ECM, in addition to any
remaining growth factors, could potentially stimulate cellular
activity. While testing of this scaffold indicated acceptable biocom-
patibility in vitro, it would nevertheless be unsuitable for in vivo
applications due to a potential immune response.5. Conclusion
In conclusion, the conventional peracetic acid/agitation method
for SIS decellularization is not suitable for SIS when made in intacttubular form. The primary reason for this is the insufﬁcient level of
decellularization. Peracetic acid, when used over 12 h with the per-
fusion method, was also found to be unsuitable, owing to a drastic
drop in the elasticity of the tissue following decellularization.
The two detergent/perfusion protocols were found not only to pro-
vide adequate decellularization of the SIS, but in several instances
were found to possess less adversely affected mechanical proper-
ties over the SIS produced from peracetic acid or the control
particularly following processing. There are, however, limitations
associated with both methods. It was concluded that SDS/TX was
the most suitable protocol for producing scaffolds because: it
caused the highest level of decellularization therefore posed the
least risk of an immune response and/or graft rejection; it pro-
duced the SIS with the most advantageous properties following
the processing stage; and ﬁnally, the protocol lacked enzymes as
used in SD/DNase, which may potentially increase the risk of
rejection. However, as shown in Fig. 10, the biocompatibility of
the scaffold cannot be improved even by increasing the washing
time to 6 h and using an improved washing method. Consequently,
whilst there may be some merit in research into improving the
wash cycle, it was deemed that longer time periods would not be
practical. It was observed that, whilst SD/DN may show acceptable
in vitro biocompatibility and suitable mechanical properties, it has
the limitation of using the DNase enzyme, which may be unsuit-
able for clinical application. In conclusion, SIS produced using SD
with a stage to eliminate the DNase enzyme could potentially be
the ideal basis for future work.Acknowledgement
This work was supported by the Priority Research Centers Pro-
gram (No. 2009-0093829) through the National Research Founda-
tion, Republic of Korea.Appendix A. Figures with essential colour discrimination
Certain ﬁgures in this article, particularly Figures 1–4 and 6–10,
are difﬁcult to interpret in black and white. The full colour images
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